Title: Mutant ADA2 in Vasculopathies
Authors: Van Eyck, Lien
Liston, Adrian
Wouters, Carine # ×
Issue Date: Jul-2014
Series Title: New England Journal of Medicine vol:371 issue:5 pages:480-480
Abstract: To the Editor: Zhou et al.(1) and Navon Elkan et al.(2) (both in the March 6 issue) speculate that hematopoietic stem-cell transplantation (HSCT) or enzyme-replacement therapy may be beneficial in patients with adenosine deaminase 2 (ADA2) deficiency. We report the clinical course of two brothers with recently diagnosed ADA2 deficiency resulting from a homozygous mutation in CECR1 (p.R169Q). One sibling underwent HSCT in 2003. (CECR1 encodes the protein ADA2.) One brother presented in 1999, at 6 months of age, with livedo reticularis, hepatosplenomegaly, hypercoagulability, granulocytopenia, and complete red-cell aplasia. He underwent HSCT in 2003 for a presumed diagnosis of . . .
ISSN: 0028-4793
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Genetics of Autoimmunity
Laboratory of Pediatric Immunology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
NEJMc1405506.pdf Published 372KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science